LifT BioSciences Company

Cell therapy to destroy solid tumours through Neutrophil Only Leukocyte Infusion Therapy (N-LIfT)
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Founded Date: 2016
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: 2843855
Last Funding Date: 2019
Last Funding Type: Series A

Visit Website
info@LIfTBioSciences.com
Register and Claim Ownership